BDPTD and BDPT Related Headlines
Go Back- BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
- BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
- BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
- BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
- BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
- BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
BDPTD and BDPT Related Press Releases
Go Back- BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
- BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
- BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
- BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
- BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
- BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
BDPTD and BDPT Related SEC Filings
Go Back- Form 4 BIOADAPTIVES, INC. For: Aug 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Jul 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Jun 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: May 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Apr 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Mar 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Feb 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Jan 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Dec 01 Filed by: FRISSORA MARK P
- Form 10-Q BIOADAPTIVES, INC. For: Sep 30
- Form 4 BIOADAPTIVES, INC. For: Nov 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Oct 01 Filed by: FRISSORA MARK P
- Form 4 BIOADAPTIVES, INC. For: Sep 01 Filed by: FRISSORA MARK P
